3,8,13,18-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro 21H,23H-Porphine-2,7,12,17-tetrapropanoic acid
|
|
3,8,13,18-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro 21H,23H-Porphine-2,7,12,17-tetrapropanoic acid Eigenschaften
Sicherheit
3,8,13,18-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro 21H,23H-Porphine-2,7,12,17-tetrapropanoic acid Chemische Eigenschaften,Einsatz,Produktion Methoden
3,8,13,18-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro 21H,23H-Porphine-2,7,12,17-tetrapropanoic acid Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3,8,13,18-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro 21H,23H-Porphine-2,7,12,17-tetrapropanoic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 2)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Shanghai Anyinuo Biomedical Technology Co., Ltd. | 021-34625901 |
420970979@qq.com | China | 5795 | 58 |
- 3,8,13,18-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro 21H,23H-Porphine-2,7,12,17-tetrapropanoic acid
- Uroporphyrinogen I
- 2,7,12,17-Tetrakis(2-oxo-2-hydroxyethyl)-3,8,13,18-tetrakis(3-oxo-3-hydroxypropyl)-5,10,15,20,22,24-hexahydro-21H,23H-porphyrin
- 5,10,15,20,22,24-Hexahydrouroporphyrin I
- Cbi
- cobyrinic acid a,c-diamide
- 1867-62-5
- C40H44N4O16